1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Drug Modelling Software Market – By Product Type

1.3.2        North America Drug Modelling Software Market – By Application

1.3.3        North America Drug Modelling Software Market – By Country

2.           North America Drug Modelling Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Drug Modelling Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Drug Modelling Software Market - North America PEST Analysis

4.3         Expert Opinion

5.           North America Drug Modelling Software Market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Adoption of Modelling Tools in Drug Discovery

5.1.2        Increasing Economic Burden of Drug Discovery

5.2         Key Market Restraints

5.2.1        Lack of Data Standardization

5.3         Key Market Opportunities

5.3.1        Strategic Activities by Market Players

5.4         Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5         Impact analysis

6.           Drug Modelling Software Market – North America Analysis

6.1         North America Drug Modelling Software Market Revenue Forecasts and Analysis

7.           North America Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         North America Drug Modelling Software Market, By Type 2019 & 2027 (%)

7.2.1        North America Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Database

7.3.1        Overview

7.3.2        North America Database Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Software

7.4.1        Overview

7.4.1.1          North America Software Revenue and Forecasts to 2027 (US$ Mn)

7.5         Other Product Types

7.5.1        Overview

7.5.2        North America Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

8.           North America Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application

8.1         Overview

8.2         North America Drug Modelling Software Market, By Application 2019 & 2027 (%)

8.2.1        North America Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        North America Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Computational Physiological Medicine

8.4.1        Overview

8.4.2        North America Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Disease Modelling

8.5.1        Overview

8.5.2        North America Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Medical Imaging

8.6.1        Overview

8.6.2        North America Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Predictive Analysis of Drug Targets

8.7.1        Overview

8.7.2        North America Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Simulation Software

8.8.1        Overview

8.8.2        North America Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.9         Cellular Simulation

8.9.1        Overview

8.9.2        North America Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Others

8.10.1     Overview

8.10.2     North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         North America Drug modelling software Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        North America: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        North America: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.5        North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

9.1.6        US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          US: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7        Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Canada: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.8        Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          Mexico: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on North America Drug Modelling Software Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Crown Bioscience Inc (JSR life science)

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Chemical Computing Group ULC.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Nimbus Therapeutics

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Schrödinger, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Leadscope, Inc (Instem)

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             North America Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             North America: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             US: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.             Canada: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             Mexico: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Glossary of Terms, Drug Modelling Software Market

LIST OF FIGURES

Figure 1.           Drug Modelling Software Market Segmentation

Figure 2.           North America Drug Modelling Software Market Overview

Figure 3.           Software Segment Held Largest Share of Drug Modelling Software Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Drug Modelling Software Market - Leading Country Markets (US$ Mn)

Figure 6.           Drug Modelling Software Market - North America PEST Analysis

Figure 7.           Drug Modelling Software Market Impact Analysis of Driver and Restraints

Figure 8.           North America Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           North America Drug Modelling Software Market, By Type 2019 & 2027 (%)

Figure 10.        North America Database Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        North America Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        North America Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        North America Drug Modelling Software Market, By Application 2019 & 2027 (%)

Figure 14.        North America Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        North America Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        North America Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        North America Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        North America Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        North America Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        North America Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        North America: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        North America Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

Figure 25.        US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Impact of COVID-19 Pandemic In North American Country Markets